Dr. Lal Pathlabs gets nod to acquire entire stake in Suburban Diagnostics

27 Oct 2021 Evaluate

Dr. Lal Pathlabs has received approval to acquire 100% stake in Suburban Diagnostics (India) from its existing shareholders. The objective of acquisition is to strengthen the Company’s presence in the western part of the country / State of Maharashtra. The board of directors at its meeting held on October 26, 2021 has approved the same.

Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India.

Dr. Lal Pathlabs Share Price

2650.80 23.55 (0.90%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 362.80
Apollo Hospital Ent. 5850.75
Max Healthcare Inst 752.20
Narayana Hrudayalay 1190.00
Global Health 1192.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.